KR840004366A - 과불소탄화수소류 투약용 부형제 - Google Patents

과불소탄화수소류 투약용 부형제 Download PDF

Info

Publication number
KR840004366A
KR840004366A KR1019830001426A KR830001426A KR840004366A KR 840004366 A KR840004366 A KR 840004366A KR 1019830001426 A KR1019830001426 A KR 1019830001426A KR 830001426 A KR830001426 A KR 830001426A KR 840004366 A KR840004366 A KR 840004366A
Authority
KR
South Korea
Prior art keywords
perfluorohydrocarbon
excipient
composition
excipient consists
therapeutic agent
Prior art date
Application number
KR1019830001426A
Other languages
English (en)
Other versions
KR880002038B1 (ko
Inventor
머레이 요크 빌리이
Original Assignee
이중호
앨컨 라보라토 리이즈 인코포레이팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이중호, 앨컨 라보라토 리이즈 인코포레이팃드 filed Critical 이중호
Publication of KR840004366A publication Critical patent/KR840004366A/ko
Application granted granted Critical
Publication of KR880002038B1 publication Critical patent/KR880002038B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

과불소탄화수소류 투약용 부형제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (23)

  1. 37℃에서 약 1-16mmHg의 증가압을 가진 과불소탄화수소 부형제와 치료약제로 구성된 제약용 조성물
  2. 37℃에서 약 1-16mmHg의 증기압을 가진 과불소탄화수소 부형제와 치료약제로 구성된 국소치료제용 조성물
  3. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 과불소 알칸으로 구성된 조성물
  4. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 과불소사이클로알칸으로 구성된 조성물
  5. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 C9-15의 과불소트리알킬아민으로 구성된 조성물
  6. 제1항 또는 제2항에 있어서 과불소탄화수소 부형제가 과불소데칼린으로 구성된 조성물
  7. 제1항 또는 제2항에 있어서 과불소탄화수소 부형제가 과불소트리불틸아민으로 구성된 조성물
  8. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 과불소메틸데칼린으로 구성된 조성물
  9. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 과불소사이클로헥실티에틸아민으로 구성된 조성물
  10. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 과불소이소펜틸피란인 조성물
  11. 제1항 또는 제2항에 있어서 상기 과불소탄화수소 부형제가 과불소디메틸아민으로 구성된 조성물
  12. 제1항 또는 제2항에 있어서 과불소탄화수소 부형제가 과불소부틸테트라하이드로푸란으로 구성된 조성물
  13. 37℃에서 약 1-16mmHg의 증가압을 갖는 과불탄화수소 부형제와 치료약제 유효량으로 구성된 조성물을 투여하는 것으로 구성된 치료약제의 적용법
  14. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소알칸으로 구성된 방법
  15. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소사이클로알칸으로 구성된 방법
  16. 제13항에 있어서, 상기 과불소탄화수소 부형제가 C9-15의 과불소트리알킬아민으로 구성된 방법
  17. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소데칼린으로 구성된 방법
  18. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소트리부틸아민으로 구성된 방법
  19. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소메틸데칼린으로 구성된 방법
  20. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소사이클로헥실디메틸아민으로 구성된 방법
  21. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소이소펜틸피란으로 구성된 방법
  22. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소부틸메틸아민으로 구성된 방법
  23. 제13항에 있어서, 상기 과불소탄화수소 부형제가 과불소부틸테트라하이드로푸란으로 구성된 방법
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830001426A 1982-04-05 1983-04-06 과불소-치환 화합물을 부형제로서 포함하는 약제 조성물 KR880002038B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36553982A 1982-04-05 1982-04-05
US365,539 1982-04-05

Publications (2)

Publication Number Publication Date
KR840004366A true KR840004366A (ko) 1984-10-15
KR880002038B1 KR880002038B1 (ko) 1988-10-13

Family

ID=23439275

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001426A KR880002038B1 (ko) 1982-04-05 1983-04-06 과불소-치환 화합물을 부형제로서 포함하는 약제 조성물

Country Status (12)

Country Link
EP (1) EP0091313B1 (ko)
KR (1) KR880002038B1 (ko)
AT (1) ATE56138T1 (ko)
AU (1) AU557980B2 (ko)
CA (1) CA1295948C (ko)
DE (1) DE3381854D1 (ko)
GR (1) GR78151B (ko)
IE (1) IE56412B1 (ko)
IL (1) IL68456A (ko)
NZ (1) NZ203802A (ko)
PT (1) PT76504B (ko)
WO (1) WO1983003544A1 (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559559B2 (en) * 1982-08-17 1987-03-12 Suntech, Inc. Perfluorocarbon emulsions and their preparation and use in therapy
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
DE69226372T2 (de) * 1991-11-14 1999-04-01 Alliance Pharma Vorrichtung zur teilweisen flüssigen beatmung mit fluorkohlenwasserstoffen
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
ATE196734T1 (de) * 1993-08-18 2000-10-15 Alcon Lab Inc Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
ATE206441T1 (de) 1994-03-04 2001-10-15 Univ Washington Block- und pfropfcopolymere und dazu gehöriges verfahren
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
AU2001211986B2 (en) * 2000-10-13 2007-04-26 Cambridge Biostability Ltd. Composition and method for stable injectable liquids
DE60043459D1 (de) * 2000-10-13 2010-01-14 Cambridge Biostability Ltd Pharmazeutische flüssige Suspensionen
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
CN104755073B (zh) * 2012-09-12 2017-12-26 诺瓦利克有限责任公司 半氟化烷烃组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
BE629985A (ko) * 1962-11-29
US3490923A (en) * 1966-07-28 1970-01-20 Du Pont Aerosol propellant composition used in dispensing foods
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US3929662A (en) * 1973-12-18 1975-12-30 Wave Energy Systems Liquid or gas phase sterilizing and cleaning composition containing an aldehyde and a fluoro or perfluoro compound
US4187252A (en) * 1977-08-26 1980-02-05 Suntech, Inc. Tetramethylpentane blood substitutes
US4110474A (en) * 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPH08221312A (ja) * 1995-02-14 1996-08-30 Hitachi Ltd メモリカード装置

Also Published As

Publication number Publication date
IL68456A0 (en) 1983-07-31
EP0091313A2 (en) 1983-10-12
EP0091313B1 (en) 1990-09-05
IL68456A (en) 1989-09-28
ATE56138T1 (de) 1990-09-15
CA1295948C (en) 1992-02-18
NZ203802A (en) 1985-07-31
DE3381854D1 (de) 1990-10-11
AU557980B2 (en) 1987-01-15
PT76504A (en) 1983-05-01
IE56412B1 (en) 1991-07-31
EP0091313A3 (en) 1985-05-22
GR78151B (ko) 1984-09-26
WO1983003544A1 (en) 1983-10-27
PT76504B (en) 1986-02-27
KR880002038B1 (ko) 1988-10-13
AU1313883A (en) 1983-10-13
IE830776L (en) 1983-10-05

Similar Documents

Publication Publication Date Title
KR840004366A (ko) 과불소탄화수소류 투약용 부형제
ATE8459T1 (de) Pharmazeutische zubereitung in form eines polyacrylatfilmes und deren herstellung.
SE8202172L (sv) Topiska farmaceutiska kompositioner
NO931267D0 (no) Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
DE69229098D1 (de) Hochdosierte topische Kollagenaseformen
IT1062219B (it) Glucopiranosido..i..6..mannite..procedimento per la sua preparazione e l'impiego della stessa come surrogato dello zucchero
ATE15596T1 (de) Pharmazeutische mittel.
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
ATE6470T1 (de) Analgetische zusammensetzung.
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
NL175882B (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
DK0484112T3 (da) Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum
GB1502873A (en) Pharmaceutical compositions with ulcer healing activity
KR910009267A (ko) 우울증의 치료방법
SE7910554L (sv) Disulfidforeningar
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
SE7708176L (sv) Bensamidforeningar
SE7907621L (sv) Etomidat-haltiga kompositioner
SE7701263L (sv) Terapeutiska kompositioner och anvendning derav
KR880002535A (ko) 약제로서의 15-데옥시스퍼구알린의 용도
ES269442A1 (es) Procedimiento de preparaciën de orotato de lisina
SE7701441L (sv) Nytt piperazinyluracilsalt
KR960003728A (ko) 포유류의 허파 모세관 누출을 감소시키는 방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970930

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee